-
1.发明授权公开(公告)号：US12236595B2
公开(公告)日：2025-02-25
申请号：US18545550
申请日：2023-12-19
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , David S. Paik
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
2.发明授权公开(公告)号：US12154321B2
公开(公告)日：2024-11-26
申请号：US18504769
申请日：2023-11-08
Applicant: ELUCID BIOIMAGING INC.
Inventor： Matthew Phillips , Andrew J. Buckler
Abstract: Systems and method can be provided to transform input data (e.g., CT imaging data) into structured representations to create interpretable models. Another aspect of the current invention can be generating labels synthetically to apply to real data according to a biologically-based labelling technique to guide the model training with a priori mechanistic knowledge.
-
公开(公告)号：US12118694B2
公开(公告)日：2024-10-15
申请号：US18319053
申请日：2023-05-17
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Changguo Ji , Murali Ayyapillai
CPC classification number: G06T5/50 , A61B6/4241 , A61B6/463 , A61B6/482 , A61B6/504 , A61B6/5247 , G06T7/0012 , G06T7/174 , G06T2207/10081 , G06T2207/10088 , G06T2207/10132 , G06T2207/20216 , G06T2207/20224
Abstract: Systems and methods for improving soft tissue contrast, characterizing tissue, classifying phenotype, stratifying risk, and performing multi-scale modeling aided by multiple energy or contrast excitation and evaluation are provided. The systems and methods can include single and multi-phase acquisitions and broad and local spectrum imaging to assess atherosclerotic plaque tissues in the vessel wall and perivascular space.
-
公开(公告)号：US12039765B2
公开(公告)日：2024-07-16
申请号：US18309903
申请日：2023-05-01
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Kjell Johnson , Xiaonan Ma , Keith A. Moulton , Mark A. Buckler , Vladimir Valtchinov , David S. Paik
IPC: G06V10/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/00 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06V10/25 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/0012 , G06T7/11 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
5.发明授权公开(公告)号：US12026868B2
公开(公告)日：2024-07-02
申请号：US17314767
申请日：2021-05-07
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. Buckler , Mark A. Buckler
IPC: G06T7/00 , A61B6/00 , A61B6/50 , G06T11/00 , G06V10/20 , G06V10/56 , G16H10/60 , G16H30/20 , G16H30/40 , G16H50/20 , G16H70/60 , G06V10/94 , G16H50/30 , G16H50/70
CPC classification number: G06T7/001 , A61B6/504 , A61B6/5247 , G06T11/008 , G06V10/255 , G06V10/56 , G16H10/60 , G16H30/20 , G16H30/40 , G16H50/20 , G16H70/60 , G06T2207/10116 , G06T2207/20081 , G06T2207/30101 , G06V10/95 , G06V2201/03 , G16H50/30 , G16H50/70
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
Patent Agency Ranking
公开(公告)号：US20240161297A1
公开(公告)日：2024-05-16
申请号：US18545563
申请日：2023-12-19
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/73 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
公开(公告)号：US20240078671A1
公开(公告)日：2024-03-07
申请号：US18504795
申请日：2023-11-08
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06T7/00 , G06F18/211 , G06F18/214 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/00 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69
CPC classification number: G06T7/0012 , G06F18/211 , G06F18/2148 , G06F18/24 , G06N3/08 , G06N20/00 , G06T3/00 , G06T5/003 , G06T7/11 , G06V10/25 , G06V10/764 , G06V20/69 , G06T2207/10048 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10132 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
8.发明公开公开(公告)号：US20240046457A1
公开(公告)日：2024-02-08
申请号：US18232246
申请日：2023-08-09
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
CPC classification number: G06T7/0012 , A61B5/055 , G16B5/00 , G16C20/30 , G16H20/00 , G06T2207/10088 , G06T2207/30101
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a combination of any two or more therapies selected from a lipid-lowering therapy, an anti-inflammatory therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
9.发明公开公开(公告)号：US20240006066A1
公开(公告)日：2024-01-04
申请号：US18243138
申请日：2023-09-07
Applicant: Elucid Bioimaging Inc.
Inventor： Andrew J. Buckler , Ulf Hedin , Ljubica Matic , Matthew Phillips
Abstract: Provided herein are methods and systems for making patient-specific therapy recommendations of a lipid-lowering therapy for patients with known or suspected cardiovascular disease, such as atherosclerosis.
-
10.发明公开公开(公告)号：US20230326166A1
公开(公告)日：2023-10-12
申请号：US18307316
申请日：2023-04-26
Applicant: ELUCID BIOIMAGING INC.
Inventor： Andrew J. BUCKLER , Kjell JOHNSON , Xiaonan MA , Keith A. MOULTON , David S. PAIK
IPC: G06V10/25 , G06T7/00 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/00 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/214 , G06V10/764
CPC classification number: G06V10/25 , G06T7/0012 , G06T7/11 , G06N20/00 , G06N3/08 , G06T5/003 , G06T3/00 , G06V20/69 , G06F18/24 , G06F18/211 , G06F18/2148 , G06V10/764 , G06T2207/10132 , G06T2207/10081 , G06T2207/10088 , G06T2207/10101 , G06T2207/10104 , G06T2207/10108 , G06T2207/10048 , G06T2207/20081 , G06T2207/30096 , G06T2207/30104
Abstract: Systems and methods for analyzing pathologies utilizing quantitative imaging are presented herein. Advantageously, the systems and methods of the present disclosure utilize a hierarchical analytics framework that identifies and quantify biological properties/analytes from imaging data and then identifies and characterizes one or more pathologies based on the quantified biological properties/analytes. This hierarchical approach of using imaging to examine underlying biology as an intermediary to assessing pathology provides many analytic and processing advantages over systems and methods that are configured to directly determine and characterize pathology from underlying imaging data.
-
-
-
-
-
-
-
-
-
Search Results
98
records
(took 0.028 seconds)
